These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37547160)

  • 21. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort.
    Imajo K; Tetlow L; Dennis A; Shumbayawonda E; Mouchti S; Kendall TJ; Fryer E; Yamanaka S; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Saito S; Kelly C; Kelly MD; Banerjee R; Nakajima A
    World J Gastroenterol; 2021 Feb; 27(7):609-623. PubMed ID: 33642832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center.
    Shen M; Lee A; Lefkowitch JH; Worman HJ
    J Clin Transl Hepatol; 2022 Apr; 10(2):197-206. PubMed ID: 35528980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
    Gao F; Huang JF; Zheng KI; Pan XY; Ma HL; Liu WY; Byrne CD; Targher G; Li YY; Chen YP; Chan WK; Zheng MH
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1804-1812. PubMed ID: 32246876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative accuracy of endosonographic shear wave elastography and transcutaneous liver stiffness measurement: a pilot study.
    Kohli DR; Mettman D; Andraws N; Haer E; Porter J; Ulusurac O; Ullery S; Desai M; Siddiqui MS; Sharma P
    Gastrointest Endosc; 2023 Jan; 97(1):35-41.e1. PubMed ID: 36049537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
    Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.
    Kim D; Kim WR; Talwalkar JA; Kim HJ; Ehman RL
    Radiology; 2013 Aug; 268(2):411-9. PubMed ID: 23564711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity.
    Chen J; Yin M; Talwalkar JA; Oudry J; Glaser KJ; Smyrk TC; Miette V; Sandrin L; Ehman RL
    Radiology; 2017 May; 283(2):418-428. PubMed ID: 27861111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.
    Tapper EB; Sengupta N; Hunink MG; Afdhal NH; Lai M
    Am J Gastroenterol; 2015 Sep; 110(9):1298-304. PubMed ID: 26303130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD.
    Argalia G; Ventura C; Tosi N; Campioni D; Tagliati C; Tufillaro M; Cucco M; Svegliati Baroni G; Giovagnoni A
    Radiol Med; 2022 May; 127(5):571-576. PubMed ID: 35290569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis.
    Sangha K; Chang ST; Cheung R; Deshpande VS
    Hepatology; 2023 May; 77(5):1702-1711. PubMed ID: 37018145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Thiele M; Madsen BS; Hansen JF; Detlefsen S; Antonsen S; Krag A
    Gastroenterology; 2018 Apr; 154(5):1369-1379. PubMed ID: 29317276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
    Afdhal NH; Bacon BR; Patel K; Lawitz EJ; Gordon SC; Nelson DR; Challies TL; Nasser I; Garg J; Wei LJ; McHutchison JG
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):772-9.e1-3. PubMed ID: 25528010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Honda Y; Imajo K; Kobayashi T; Kessoku T; Ogawa Y; Tomeno W; Yoneda M; Kobayashi N; Saito S; Nakajima A
    Hepatol Res; 2019 Oct; 49(10):1136-1146. PubMed ID: 31144415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
    Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy.
    Morse CG; McLaughlin M; Proschan M; Koh C; Kleiner DE; Heller T; Kovacs JA
    AIDS; 2015 Nov; 29(17):2297-302. PubMed ID: 26544701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Tovo CV; Villela-Nogueira CA; Leite NC; Panke CL; Port GZ; Fernandes S; Buss C; Coral GP; Cardoso AC; Cravo CM; Calçado FL; Rezende GFM; Ferreira FC; Araujo-Neto JM; Perez RM; Moraes-Coelho HS; de Mattos AA
    Ann Hepatol; 2019; 18(3):445-449. PubMed ID: 31031166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
    Sanyal AJ; Foucquier J; Younossi ZM; Harrison SA; Newsome PN; Chan WK; Yilmaz Y; De Ledinghen V; Costentin C; Zheng MH; Wai-Sun Wong V; Elkhashab M; Huss RS; Myers RP; Roux M; Labourdette A; Destro M; Fournier-Poizat C; Miette V; Sandrin L; Boursier J
    J Hepatol; 2023 Feb; 78(2):247-259. PubMed ID: 36375686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.